Critchlow C W, Surawicz C M, Holmes K K, Kuypers J, Daling J R, Hawes S E, Goldbaum G M, Sayer J, Hurt C, Dunphy C
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle 98195, USA.
AIDS. 1995 Nov;9(11):1255-62. doi: 10.1097/00002030-199511000-00007.
To determine the risk of developing high grade anal squamous intraepithelial neoplasia (HG-AIN) in relation to HIV infection and immunosuppression, after controlling for the effects of human papillomavirus (HPV) infection.
Prospective cohort study of 158 HIV-seropositive and 147 HIV-seronegative homosexual men presenting to a community-based clinic with initially negative anal cytologic and colposcopic findings.
Subjects completed self-administered questionnaires, underwent cytologic screening, and standardized unaided and colposcopic examination of the proximal anal canal for presence of abnormalities suggestive of AIN. Anal specimens were screened for HPV DNA.
HG-AIN developed in eight (5.4%) and 24 (15.2%) HIV-seronegative and -seropositive men, respectively. Risk of HG-AIN among HIV-seronegative men was associated with detection of anal HPV types 16 or 18 by Southern transfer hybridization (STH), detection of HPV 16 or 18 at the lower levels by polymerase chain reaction but not by STH, and with number of positive HPV tests; HG-AIN risk among HIV-seropositive men was associated with detection of HPV 16 or 18 only by STH, detection of HPV types other than 16 or 18, CD4 count < or = 500 x 10(6)/l, and number of positive HPV tests. HIV-induced immunosuppression remained an independent predictor of HG-AIN after adjusting for type and level of detection of HPV; HIV infection predicted HG-AIN risk after adjustment for number of positive HPV tests.
The association of HG-AIN with HIV, independent of HPV type, level of HPV detection and number of positive HPV tests, suggests that this increased risk cannot be entirely explained by an effect of HIV on HPV detection. Future studies focusing on factors more specific to the local microenvironment in the anal canal should help clarify these issues.
在控制人乳头瘤病毒(HPV)感染影响的情况下,确定与HIV感染和免疫抑制相关的高级别肛门鳞状上皮内瘤变(HG-AIN)发生风险。
对158名HIV血清阳性和147名HIV血清阴性的同性恋男性进行前瞻性队列研究,这些男性到一家社区诊所就诊,最初肛门细胞学和阴道镜检查结果为阴性。
受试者完成自行填写的问卷,接受细胞学筛查,并对肛管近端进行标准化的徒手和阴道镜检查,以确定是否存在提示AIN的异常。对肛门标本进行HPV DNA筛查。
分别有8名(5.4%)HIV血清阴性男性和24名(15.2%)HIV血清阳性男性发生HG-AIN。HIV血清阴性男性中HG-AIN的风险与通过Southern印迹杂交(STH)检测到肛门HPV 16或18型、通过聚合酶链反应在较低水平检测到HPV 16或18但未通过STH检测到以及HPV检测阳性次数有关;HIV血清阳性男性中HG-AIN的风险与仅通过STH检测到HPV 16或18、检测到16或18型以外的HPV类型、CD4计数≤500×10⁶/L以及HPV检测阳性次数有关。在调整HPV检测类型和水平后,HIV诱导的免疫抑制仍然是HG-AIN的独立预测因素;在调整HPV检测阳性次数后,HIV感染可预测HG-AIN风险。
HG-AIN与HIV相关,独立于HPV类型、HPV检测水平和HPV检测阳性次数,这表明这种风险增加不能完全由HIV对HPV检测的影响来解释。未来关注肛管局部微环境更特异性因素的研究应有助于阐明这些问题。